North American Coral Snake Antivenin (equine) Injection, Powder, For Solution
Product Images NDC 0008-0423

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for North American Coral Snake Antivenin (equine) (NDC 0008-0423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Antivenin 01)

Logo (Antivenin 01)
This is a description of the manufacturer of a pharmaceutical product called 'Wyeth Pharmaceuticals LLC'. The company is a subsidiary of Pfizer Inc, located in Philadelphia with a postal code of 19101.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
This appears to be a section of a pharmaceutical product label for a coral snake antivenin. It includes information about dosage and use, prescribing information, reconstitution instructions, and the manufacturer. The NDC (National Drug Code) and a government license number are also listed. However, the illegible characters and lack of context make it difficult to provide a more specific description.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
This package contains an antivenin for North American Coral Snake bites which is intended for intravenous injection. Each vial is standardized for potency in mice and contains approximately 2 mg of M. fulvius venom. The product is ideally stored between 2° and 8° C (36° and 46° F) and should be used within 4 hours of reconstitution and dilution. The enclosed prescribing information provides the dosage, reconstitution, and administration instructions. The manufacturer is Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., Philadelphia, PA 19101. No other information is available due to the medical nature of the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.